Evidence map›Paper›PMID 34888488›Full record

ArticleArchives of clinical and biomedical research2021

Erratum: miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs.

Arlet María Acanda de la Rocha, Marisol González-Huarriz, Elizabeth Guruceaga, Nicole Mihelson, Sonia Tejada-Solís, Ricardo Díez-Valle, Naiara Martínez-Vélez, Juan Fueyo, Candelaria Gomez-Manzano, Marta M Alonso and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of clinical and biomedical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Arlet María Acanda de la RochaThe Health Research Institute of Navarra (IDISNA), USA.
Marisol González-HuarrizThe Health Research Institute of Navarra (IDISNA), USA.
Elizabeth GuruceagaThe Health Research Institute of Navarra (IDISNA), USA.
Nicole MihelsonHugo W Moser Research Institute at Kennedy Krieger, Baltimore, MD, USA.
Sonia Tejada-SolísThe Health Research Institute of Navarra (IDISNA), USA.
Ricardo Díez-ValleThe Health Research Institute of Navarra (IDISNA), USA.
Naiara Martínez-VélezThe Health Research Institute of Navarra (IDISNA), USA.
Juan FueyoDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Candelaria Gomez-ManzanoDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Marta M AlonsoThe Health Research Institute of Navarra (IDISNA), USA.
John LaterraHugo W Moser Research Institute at Kennedy Krieger, Baltimore, MD, USA.
Hernando López-BertoniHugo W Moser Research Institute at Kennedy Krieger, Baltimore, MD, USA.

Funding

Chromatin Modifications in GBM-Propagating CellsR01NS096754 · NINDS · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI LATERRA, JOHN J · 2017 to 2021
$2.2M
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.R01NS120949 · NINDS · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI LOPEZ-BERTONI, HERNANDO MARTIN · 2021 to 2025
$2.0M
Brain Cancer Stem Cell Reprogramming by c-MetR01NS073611 · NINDS · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI LATERRA, JOHN J · 2012 to 2016
$1.8M
NINDS NIH HHS R01 NS073611NINDS NIH HHS R01 NS096754NINDS NIH HHS R01 NS120949
6 · The paper itself

Abstract

[This corrects the article PMC7470213.].

Identifiers

PMID34888488
PMCPMC8654198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.